H-Tyr-Ser-Pro-Trp-Thr-Asn-Phe-OH |
| Catalog No.GA22987 |
The heptapeptide YSPWTNF has been shown to prevent cellulitis in mice, which was induced by S. aureus strain Smith diffuse. Furthermore, RIP can also significantly reduce the overall pathology and delay the onset of disease symptoms in several other S. aureus infections, including keratitis, osteomyelitis, mastitis, and septic arthritis. These findings strongly evidence the potential value of RIP as a chemotherapeutic agent.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 228544-21-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
The heptapeptide YSPWTNF has been shown to prevent cellulitis in mice, which was induced by S. aureus strain Smith diffuse. Furthermore, RIP can also significantly reduce the overall pathology and delay the onset of disease symptoms in several other S.
Average Rating: 5 (Based on Reviews and 33 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *